These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 2511197)

  • 1. The 75,000-dalton interleukin-2 receptor transmits a signal for the activation of a tyrosine protein kinase.
    Saltzman EM; Luhowskyj SM; Casnellie JE
    J Biol Chem; 1989 Nov; 264(33):19979-83. PubMed ID: 2511197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stimulation of the antigen and interleukin-2 receptors on T lymphocytes activates distinct tyrosine protein kinases.
    Saltzman EM; White K; Casnellie JE
    J Biol Chem; 1990 Jun; 265(17):10138-42. PubMed ID: 2351654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergistic action of monoclonal antibodies directed at p55 and p75 chains of the human IL-2-receptor.
    Audrain M; Boeffard F; Soulillou JP; Jacques Y
    J Immunol; 1991 Feb; 146(3):884-92. PubMed ID: 1988501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The beta-chain of the IL-2 receptor (p70) is tyrosine-phosphorylated on YT and HUT-102B2 cells.
    Sharon M; Gnarra JR; Leonard WJ
    J Immunol; 1989 Oct; 143(8):2530-3. PubMed ID: 2477446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of the interleukin 2 receptor complex tyrosine kinase activity in vitro.
    Michiel DF; Garcia GG; Evans GA; Farrar WL
    Cytokine; 1991 Sep; 3(5):428-38. PubMed ID: 1751780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression and functional role of the p75 interleukin 2 receptor chain on leukemic hairy cells.
    Trentin L; Zambello R; Benati C; Cassatella M; Agostini C; Bulian P; Adami F; Carra G; Pizzolo G; Semenzato G
    Cancer Res; 1992 Oct; 52(19):5223-8. PubMed ID: 1394125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural killer cells activated by interleukin 2 treatment in vivo respond to interleukin 2 primarily through the p75 receptor and maintain the p55 (TAC) negative phenotype.
    Weil-Hillman G; Voss SD; Fisch P; Schell K; Hank JA; Sosman JA; Sugamura K; Sondel PM
    Cancer Res; 1990 May; 50(9):2683-91. PubMed ID: 1691679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of IL-2 interaction with p75 and p55 receptor molecules in the stimulation of cell proliferation.
    Perkins GR; Flemming CL; Kabat D; Collins MK
    Int Immunol; 1993 May; 5(5):541-9. PubMed ID: 8318457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two-dimensional analysis of interleukin 2-regulated tyrosine kinase activation mediated by the p70-75 beta subunit of the interleukin 2 receptor.
    Farrar WL; Ferris DK
    J Biol Chem; 1989 Jul; 264(21):12562-7. PubMed ID: 2787319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of a tyrosine kinase activity associated with the high-affinity interleukin 2 receptor complex.
    Garcia GG; Evans GA; Michiel DF; Farrar WL
    Biochem J; 1992 Aug; 285 ( Pt 3)(Pt 3):851-6. PubMed ID: 1497623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A tyrosine kinase physically associates with the beta-subunit of the human IL-2 receptor.
    Fung MR; Scearce RM; Hoffman JA; Peffer NJ; Hammes SR; Hosking JB; Schmandt R; Kuziel WA; Haynes BF; Mills GB
    J Immunol; 1991 Aug; 147(4):1253-60. PubMed ID: 1869821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ligand-stimulated tyrosine phosphorylation of the IL-2 receptor beta chain and receptor-associated proteins.
    Shackelford DA; Trowbridge IS
    Cell Regul; 1991 Jan; 2(1):73-85. PubMed ID: 2007186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The p75 peptide is the receptor for interleukin 2 expressed on large granular lymphocytes and is responsible for the interleukin 2 activation of these cells.
    Tsudo M; Goldman CK; Bongiovanni KF; Chan WC; Winton EF; Yagita M; Grimm EA; Waldmann TA
    Proc Natl Acad Sci U S A; 1987 Aug; 84(15):5394-8. PubMed ID: 3110786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin 2 regulates the activity of the lyn protein-tyrosine kinase in a B-cell line.
    Torigoe T; Saragovi HU; Reed JC
    Proc Natl Acad Sci U S A; 1992 Apr; 89(7):2674-8. PubMed ID: 1557373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Different mechanisms of activation of proliferating CD3+ cells in patients with lymphoproliferative disease of granular lymphocytes.
    Zambello R; Cassatella MA; Trentin L; Bulian P; Siviero F; Feruglio C; Agostini C; Vespignani M; Chisesi T; Pizzolo G
    Leukemia; 1991 Nov; 5(11):942-50. PubMed ID: 1835747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for p55-p75 heterodimers in the absence of IL-2 from Scatchard plot analysis.
    Goldstein B; Jones D; Kevrekidis IG; Perelson AS
    Int Immunol; 1992 Jan; 4(1):23-32. PubMed ID: 1540547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contribution of a p75 interleukin 2 binding peptide to a high-affinity interleukin 2 receptor complex.
    Tsudo M; Kozak RW; Goldman CK; Waldmann TA
    Proc Natl Acad Sci U S A; 1987 Jun; 84(12):4215-8. PubMed ID: 3108887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transmembrane signaling by the interleukin-2 receptor: progress and conundrums.
    Mills GB; Schmandt R; Gibson S; Leung B; Hill M; May C; Shi YF; Branch DR; Radvanyi L; Truitt KE
    Semin Immunol; 1993 Oct; 5(5):345-64. PubMed ID: 8260651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of JAK3, but not JAK1, is critical for IL-2-induced proliferation and STAT5 recruitment by a COOH-terminal region of the IL-2 receptor beta-chain.
    Kirken RA; Rui H; Malabarba MG; Howard OM; Kawamura M; O'Shea JJ; Farrar WL
    Cytokine; 1995 Oct; 7(7):689-700. PubMed ID: 8580378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neither the LCK nor the FYN kinases are obligatory for IL-2-mediated signal transduction in HTLV-I-infected human T cells.
    Mills GB; Arima N; May C; Hill M; Schmandt R; Li J; Miyamoto NG; Greene WC
    Int Immunol; 1992 Nov; 4(11):1233-43. PubMed ID: 1472476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.